EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD.
EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD. is ACRA -registered entity that has been operating for 19 years 7 months in Singapore since its incorporation in 2006.
Officially, EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD. is registered as Private Limited Company with its address 152 BEACH ROAD, #15-07/08, GATEWAY EAST, Singapore 189721.
Country of registration | Singapore |
Registration number | 200614792C |
Local SIC | |
Incorporation date | 5 Oct 2006 |
Company age | 19 years 7 months |
Official entity type | Private Limited Company |
No. of officers | 20 |
Contact
152 BEACH ROAD, #15-07/08, GATEWAY EAST, Singapore 189721
This is the legal entity page of EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- EISAI (M) SDN BHDView MoreMalaysia
- View MoreAt Eisai Oncology Global Medical Affairs, we are driven to pursue innovative solutions to help address cancers with unmet needs. human health care (hhc) is our goal. At Eisai, everything we do is guided by a simple principle: patients and their families come first, and we have a responsibility to listen to and learn from them. We call this human health care or hhc. During these unprecedented times, our hhc mission is as important as ever. At Eisai, we recognize the mental and physical challenges cancer patients and their loved ones face each day. Therefore, it is our responsibility to share our research and development programs through online channels, so that health care professionals, researchers, and scientists have up-to-date information and access. Community Guidelines:
- EISAI CO., LTD.View MoreJapanEisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology. In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), with working on various activities together with global partners.
Fiscal/Budgeting Period | January - March |
Auditor | DELOITTE & TOUCHE LLP |
Revenue | 1m - 5m |
Financial period end date | 31 Mar 2022 |
Share Capital - Ordinary shares | SGD 10,000 |
Frequently Asked Questions (FAQ)
- What is the address of EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD.?
- Where is EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD.'s headquarter?
- What is EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD.'s contact number?
- What EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD.'s spending power?
- Does EISAI CLINICAL RESEARCH SINGAPORE PTE. LTD. have a presence in the domain it operates in?

